Carbon Health is a tech-enabled healthcare company founded in 2015 and headquartered in San Francisco, California. It provides a mobile application that facilitates primary care services, allowing users to manage their treatment plans, prescriptions, and lab reports in one place. The company offers omnichannel care through various access points, including clinics, pop-up sites, video consultations, and its application, ensuring convenient and accessible healthcare for patients. Additionally, Carbon Health developed a coronavirus assessment tool and has established COVID-19 testing sites in California, further enhancing its commitment to delivering comprehensive healthcare services.
Operator of a digital addiction treatment platform intended to provide digital treatment delivered through a smartphone application. The company provides a mobile technology that uses contingency management and other types of reward systems as engagement techniques to drive member retention and better outcomes, helping patients to get rid of alcohol and drug addiction use.
Operator of a consumer health company intended to provide men with content, community, and clinical support to optimize them in mind and body. The company provides at-home lab tests and treatment, online group health coaching for nutrition, exercise, sleep, and focus, and also offers telemedicine and mail-order pharmacy services, enabling men to optimize their hormones and health.
Osmind Inc. specializes in developing healthcare software tailored for mental health providers and their patients, particularly focusing on treatment-resistant mental health conditions. Founded in 2020 and based in California, the company aims to enhance clinical care and streamline workflows for providers through its innovative software solutions. Osmind's tools not only facilitate improved patient care but also support the advancement of novel therapeutics, precision diagnostics, and care management programs. The company's mission is to increase patient access to effective mental health treatments that can succeed where traditional therapies may not.
Octant Bio is focused on advancing health and treating complex diseases through innovative synthetic technology. The company utilizes a combination of synthetic biology, genome engineering, next-generation sequencing, and computational methods to assess the activity of numerous receptor pathways within human cells. This approach allows for the development of multi-targeted small molecule drug leads by leveraging machine learning to engineer compounds that interact with multiple receptors. By generating extensive multi-receptor pathway data, Octant Bio aims to enhance rational drug design and uncover new therapeutic possibilities. Founded in 2017 and based in Los Angeles, California, Octant Bio is dedicated to transforming the landscape of drug discovery and development.
Octant Bio is focused on advancing health and treating complex diseases through innovative synthetic technology. The company utilizes a combination of synthetic biology, genome engineering, next-generation sequencing, and computational methods to assess the activity of numerous receptor pathways within human cells. This approach allows for the development of multi-targeted small molecule drug leads by leveraging machine learning to engineer compounds that interact with multiple receptors. By generating extensive multi-receptor pathway data, Octant Bio aims to enhance rational drug design and uncover new therapeutic possibilities. Founded in 2017 and based in Los Angeles, California, Octant Bio is dedicated to transforming the landscape of drug discovery and development.
Levels Health Inc. is a New York-based company that specializes in health and wellness through its innovative biowearable device utilizing continuous glucose monitoring (CGM) technology. Founded in 2019, Levels offers a platform that tracks real-time blood glucose levels, allowing consumers to understand how their diet and exercise affect their metabolic health. Through its online application, the company provides users with actionable feedback to optimize their lifestyle choices for better metabolic fitness. As a remote-first organization, Levels aims to empower individuals to take charge of their health by leveraging technology to monitor and improve their metabolic well-being.
Centenara Labs is a biotechnology company that focuses on developing innovative drug therapies aimed at improving and prolonging human lifespan. Founded in 2019 and headquartered in Zug, Switzerland, the company invests in research and technologies that target age-related diseases. Centenara Labs operates as a fully integrated platform, providing a range of services including drug discovery expertise, financial support, and administrative services. Its mission is to advance scientific understanding and create effective solutions that enable individuals to experience healthier and longer lives.
PairTree engages in modernizing the adoption process. It uses future-forward technology to connect adoptive parents with birth moms.
Kindbody is a health and technology company focused on providing comprehensive fertility services tailored for modern women. Their offerings include intrauterine insemination, in-vitro fertilization, egg and embryo freezing, as well as support for donors. In addition to fertility treatments, Kindbody provides a range of holistic health services, including maternity care, gynecology, and wellness support. By leveraging modern technology, Kindbody aims to improve access to affordable healthcare, ensuring that women can receive quality services that enhance their overall health and wellbeing.
HealthRhythms specializes in mental health assessment and treatment through advanced behavioral sensing services. The company collects data on everyday behaviors and routines, which it refers to as "behavioral rhythms," to provide a comprehensive understanding of mental wellbeing. By utilizing deep machine learning and predictive analytics, HealthRhythms offers real-time, objective monitoring of mental health status and delivers personalized interventions tailored to individual patient profiles. This innovative approach enables healthcare providers to anticipate clinical deterioration and improve the care delivery experience for patients, health plans, payers, and research organizations. Founded by experts in mental health care and information science, HealthRhythms aims to revolutionize the way mental health is measured and managed.
Alto is a full-service pharmacy powered by a team of experts dedicated to making your doctor's orders their own. From delivering prescriptions to coordinating with insurance, digging for discounts, and answering, Alto works behind-the-scenes to remove any obstacles standing in the way of your care. The company started in 2015 and is headquartered in San Francisco, California.
Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.
Developer of a behavioral health engagement platform intended to improve behavioral healthcare for underserved populations. The company's platform provides personalized care delivery services to integrate patients, providers and prescribers in the care cycle to manage the practice, enabling medical community to improve patient outcomes at minimal costs.
Bionaut Labs is a biotechnology company that specializes in developing an intra-tissue navigation platform using nano and micro-robots for medical applications. Founded in 2016 and headquartered in California, Bionaut Labs focuses on creating a delivery mechanism that allows for anatomically precise navigation within the body. The company's innovative micro-robotic technology is designed to access any anatomical location, enabling medical professionals to perform complex surgical procedures remotely and without external incisions. This advancement is achieved through an advanced remote control and imaging system that accurately guides the robots to their targets, monitors their progress, and triggers the release of therapeutic payloads at the appropriate locations and times.
Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into a novel, implantable clinical solutions that improve human lives.
Jane Technologies, Inc. operates an online marketplace for cannabis products through its platform, iheartjane.com, which offers consumers a safe and straightforward shopping experience. Founded in 2015 and based in Soquel, California, the company allows users to browse local cannabis products in real-time, comparing options by price, proximity, or popularity. This enables customers to place orders for pickup at local dispensaries without any delivery fees. Jane Technologies partners with dispensaries on a mutually beneficial model, charging stores only for completed orders at a lower cost than traditional industry software solutions.
MiResource is focused on enhancing mental health accessibility by connecting individuals, particularly young people, with licensed mental healthcare providers. The company has developed a platform that organizes and updates information about in-network therapy providers, ensuring that patients can easily find and access effective talk therapies and counseling sessions. By streamlining the connection between health systems and mental health resources, MiResource aims to create a more mentally healthy society.
Beckley Psytech Limited manufactures psychedelic drug for treating psychiatric and neurological diseases. Beckley Psytech Limited was formerly known as Beckley Psychedelics Limited and changed its name to Beckley Psytech Limited in May 2020. The company was founded in 2014 and is based in Oxford, United Kingdom.
Paradromics, Inc. is focused on developing brain-machine interfaces that facilitate data transmission between the brain and machines, primarily targeting the treatment of neurodegenerative diseases. The company creates implantable systems capable of decoding complex neural recordings into data streams, which can be utilized by various neural prostheses. Its technology emphasizes high-volume, bidirectional data streaming, allowing patients with neurological disorders to reconnect with their environment and compensate for lost biological connectivity. Founded in 2015 and headquartered in Austin, Texas, Paradromics also offers applications to support its product suite, aiming to enhance the quality of life for individuals with disabilities.
Woebot Health develops digital mental health solutions aimed at making mental health support widely accessible. Founded in 2017 and headquartered in San Francisco, the company utilizes chatbot technology to provide personalized support for mood-based disorders. Its platform integrates natural language processing with established therapeutic techniques, creating engaging interactions that deliver tailored responses to users facing specific mental health challenges. This innovative approach allows individuals to access effective mental health support conveniently, fitting seamlessly into their daily lives. Woebot Health is backed by several venture capital firms, emphasizing its commitment to advancing mental health care through technology.
Psilera is focused on developing psychedelics-based drugs aimed at improving neurological health. The company utilizes its expertise in pharmaceutical and cannabis industries to create a robust intellectual property portfolio centered on analogues derived from psychoactive precursors. Psilera formulates and screens lead compounds against various neurological targets to assess their clinical potential, with a pipeline that addresses mood disorders, cognitive diseases, and addiction. By repurposing natural psychoactive products, Psilera seeks to advance next-generation therapies that enhance mental health outcomes, ultimately aiming to alleviate human suffering.
TRIPP Inc. is a company that specializes in developing virtual reality experiences aimed at enhancing emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a development office in Chicago, TRIPP combines audio-visual elements, gameplay mechanics, and meditation to create immersive experiences that positively influence mood and mental states. Drawing on research indicating that interactive digital experiences can affect brain function, TRIPP positions itself as a pioneer in the intersection of gaming and mindfulness. By leveraging their expertise in game design, the company seeks to redefine the traditional notion of gaming, focusing on the potential of their products to serve as tools for emotional transformation rather than mere entertainment. Ultimately, TRIPP aims to help users achieve desired emotional states, fostering a unique mind-body connection through their innovative offerings.
Kindbody is a health and technology company focused on providing comprehensive fertility services tailored for modern women. Their offerings include intrauterine insemination, in-vitro fertilization, egg and embryo freezing, as well as support for donors. In addition to fertility treatments, Kindbody provides a range of holistic health services, including maternity care, gynecology, and wellness support. By leveraging modern technology, Kindbody aims to improve access to affordable healthcare, ensuring that women can receive quality services that enhance their overall health and wellbeing.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, founded in 2019. The company specializes in developing innovative psychotropic drugs aimed at treating various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Gilgamesh focuses on creating novel chemical entities through a blend of medicinal chemistry, neuroscience, and drug development expertise. By leveraging its unique approach, the company aims to provide effective therapies that enhance recovery for patients dealing with central nervous system disorders.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
LivNao Technologies leverages deep learning to detect changes in mental health before it affects performance and productivity. Their deep learning model can detect deviation before performance is affected by collecting data passively. When they have detected a change in mental health, they nudge individuals with an intervention based on their health plan. LivNao is committed to creating a healthier, happier, and more productive world, in the way they know best using data. LivNao is also 100% HIPAA-compliant. It was based in Vancouver, Canada.
Beckley Psytech Limited manufactures psychedelic drug for treating psychiatric and neurological diseases. Beckley Psytech Limited was formerly known as Beckley Psychedelics Limited and changed its name to Beckley Psytech Limited in May 2020. The company was founded in 2014 and is based in Oxford, United Kingdom.
Courage Therapeutics is a research organization that develops new medicines for eating disorders. The company was founded in 2019 and is headquartered in Newton, Massachusetts.
ATAI Life Sciences AG is a clinical-stage biopharmaceutical company headquartered in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative treatments for mental health disorders, addressing significant unmet medical needs. ATAI employs a decentralized, technology-driven platform model to accelerate the development of therapies. Its diverse portfolio includes product candidates such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and GRX-917 (Deuterated etifoxine), among others. By pooling expertise and resources, ATAI aims to create impactful, evidence-based therapies that can transform mental health treatment. The company operates primarily in Germany and the United States.
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
ATAI Life Sciences AG is a clinical-stage biopharmaceutical company headquartered in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative treatments for mental health disorders, addressing significant unmet medical needs. ATAI employs a decentralized, technology-driven platform model to accelerate the development of therapies. Its diverse portfolio includes product candidates such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and GRX-917 (Deuterated etifoxine), among others. By pooling expertise and resources, ATAI aims to create impactful, evidence-based therapies that can transform mental health treatment. The company operates primarily in Germany and the United States.
Osmind Inc. specializes in developing healthcare software tailored for mental health providers and their patients, particularly focusing on treatment-resistant mental health conditions. Founded in 2020 and based in California, the company aims to enhance clinical care and streamline workflows for providers through its innovative software solutions. Osmind's tools not only facilitate improved patient care but also support the advancement of novel therapeutics, precision diagnostics, and care management programs. The company's mission is to increase patient access to effective mental health treatments that can succeed where traditional therapies may not.
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, founded in 2019. The company specializes in developing innovative psychotropic drugs aimed at treating various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Gilgamesh focuses on creating novel chemical entities through a blend of medicinal chemistry, neuroscience, and drug development expertise. By leveraging its unique approach, the company aims to provide effective therapies that enhance recovery for patients dealing with central nervous system disorders.
Field Trip Health, Inc. providing simple, evidence-based therapies for healing and heightening engagement with the world.
Mindstrong Inc., operating as Mindstrong Health, focuses on remote patient monitoring and mental health symptom assessment through its innovative application. The platform utilizes AI-powered digital biomarker technology to enable users to monitor their mental health symptoms continuously and objectively. Mindstrong offers a range of services, including cognitive behavioral therapy, crisis management, and psychoeducation, delivered through structured messaging sessions. The company develops comprehensive care pathways that integrate passively collected data on cognitive function and mood, enhancing patient engagement through telehealth solutions. Founded in 2013 and based in Mountain View, California, Mindstrong collaborates with various stakeholders, including pharmaceutical companies, healthcare providers, and academic institutions, to advance medical innovation and improve healthcare delivery.
Foresight Mental Health is a technology-enabled company focused on providing comprehensive psychiatry and therapy services. It employs a team of psychiatrists, therapists, and psychiatric nurse practitioners who deliver treatment directly to patients in its clinics. Foresight aims to transform mental healthcare by integrating advanced technology developed by its software and biomedical engineers with clinical practice. The company offers a wide range of mental health treatments and wellness services, utilizing patient profiles that incorporate scientific research, genetic information, and detailed assessments of symptoms and brain chemistry. This holistic approach is designed to enhance patient outcomes, promoting improved mental health and overall well-being.
ATAI Life Sciences AG is a clinical-stage biopharmaceutical company headquartered in Munich, Germany, with additional offices in Berlin and London. Founded in 2018, the company focuses on developing innovative treatments for mental health disorders, addressing significant unmet medical needs. ATAI employs a decentralized, technology-driven platform model to accelerate the development of therapies. Its diverse portfolio includes product candidates such as COMP360 (Psilocybin therapy), PCN-101 (R-ketamine), and GRX-917 (Deuterated etifoxine), among others. By pooling expertise and resources, ATAI aims to create impactful, evidence-based therapies that can transform mental health treatment. The company operates primarily in Germany and the United States.
Foresight Mental Health is a technology-enabled company focused on providing comprehensive psychiatry and therapy services. It employs a team of psychiatrists, therapists, and psychiatric nurse practitioners who deliver treatment directly to patients in its clinics. Foresight aims to transform mental healthcare by integrating advanced technology developed by its software and biomedical engineers with clinical practice. The company offers a wide range of mental health treatments and wellness services, utilizing patient profiles that incorporate scientific research, genetic information, and detailed assessments of symptoms and brain chemistry. This holistic approach is designed to enhance patient outcomes, promoting improved mental health and overall well-being.
Pray.com is a social impact company based in the United States that focuses on fostering faith and community through its mobile application and website. The platform enables users to create and share prayers, access daily prayer plans, and engage with inspirational content from faith leaders and their peers. By offering faith-based social networking tools, Pray.com aims to cultivate a supportive environment where individuals can connect, grow their faith, and leave a positive legacy. The company's mission emphasizes the importance of empathy and community support, appealing to a diverse audience that includes both traditional prayer practitioners and those who seek to promote compassion and understanding in the world.